Marisa Lafontaine
Marisa Lafontaine
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed …
AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ...
JAMA oncology 6 (4), 495-503, 2020
222020
Comparison between short and long echo time magnetic resonance spectroscopic imaging at 3T and 7T for evaluating brain metabolites in patients with glioma
Y Li, M Lafontaine, S Chang, SJ Nelson
ACS chemical neuroscience 9 (1), 130-137, 2018
72018
Automated prescription and reconstruction of brain MR spectroscopy data for rapid integration into the clinical workflow
JC Crane, Y Li, MP Olson, M Lafontaine, S Maleschlijski, W Bian, ...
Neurol Disord Epilepsy 1 (1), 111, 2017
22017
Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy
P Alcaide-Leon, TL Luks, M Lafontaine, JM Lupo, H Okada, JL Clarke, ...
Journal of Neuro-Oncology 146 (1), 71-78, 2020
12020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas
J Cluceru, SJ Nelson, Q Wen, JJ Phillips, A Shai, AM Molinaro, ...
Neuro-oncology 22 (10), 1516-1526, 2020
2020
Simultaneous multi‐slice spin‐and gradient‐echo dynamic susceptibility‐contrast perfusion‐weighted MRI of gliomas
M Han, B Yang, B Fernandez, M Lafontaine, P Alcaide‐Leon, A Jakary, ...
NMR in Biomedicine, e4399, 2020
2020
Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma
AW Autry, JW Gordon, HY Chen, M LaFontaine, R Bok, M Van Criekinge, ...
NeuroImage: Clinical 27, 102323, 2020
2020
CBMT-36. INITIAL EXPERIENCE WITH HYPERPOLARIZED [2-13C]PYRUVATE MR IMAGING IN PATIENTS WITH IDH-MUTANT GLIOMA
A Autry, B Chung, HY Chen, J Gordon, M Lafontaine, S Chang, ...
Neuro-Oncology 21 (Supplement_6), vi41-vi41, 2019
2019
GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA
S Hilz, C Hong, L Jalbert, T Mazor, M Martin, A Kumar, S Shelton, K Wong, ...
Neuro-Oncology 21 (Supplement_6), vi107-vi108, 2019
2019
SERIAL CHARACTERIZATION OF HYPERPOLARIZED [1-C-13] PYRUVATE METABOLISM IN PATIENTS WITH GLIOMA AND THE INFLUENCE OF BEVACIZUMAB
A Autry, J Gordon, HY Chen, M Lafontaine, J Villanueva-Meyer, S Chang, ...
NEURO-ONCOLOGY 21, 38-39, 2019
2019
NIMG-45. 3D SINGLE-SCAN FOR MULTI-CONTRAST-WEIGHTED MRI FOR LESION DETECTION IN PATIENTS WITH GLIOMAS
J Liu, A Jakary, M Lafontaine, Y Wang, D Xu, D Saloner, N Butowski, ...
Neuro-oncology 21 (Supplement_6), 2019
2019
NIMG-33. TUMOR GROWTH AND MRI TRAJECTORIES IN GRADE II AND III GLIOMA
T Luks, Y Li, P Alcaide-Leon, M Lafontaine, A Jakary, S Chang, ...
Neuro-oncology 21 (Supplement_6), 2019
2019
NIMG-57. SERIAL HYPERPOLARIZED 13C PYRUVATE AND 1H METABOLIC IMAGING IN RECURRENT HIGH-GRADE GLIOMA
J Villanueva-Meyer, A Autry, J Gordon, HY Chen, M Lafontaine, S Chang, ...
Neuro-oncology 21 (Supplement_6), 2019
2019
SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA
A Molinaro, S Hervey-Jumper, S J. Han, R Morshed, M Lafontaine, ...
Neuro-Oncology 20 (suppl_6), vi250-vi250, 2018
2018
NIMG-11. DIFFERENTIATING TREATMENT-INDUCED EFFECTS FROM TRUE RECURRENT HIGH GRADE GLIOMA USING MULTIPARAMETRIC MRI TECHNIQUES
J Cluceru, S Nelson, A Molinaro, JJ Phillips, B Olson, M Lafontaine, ...
Neuro-Oncology 20 (suppl_6), vi177-vi178, 2018
2018
DIFFUSION MRI PRECURSORS TO PROGRESSION IN GRADE II AND III GLIOMA: NIMG-24.
T Luks, Y Li, M Lafontaine, A Jakary, G Inamdar, M Wahl, S Chang, ...
Neuro-oncology 20, 2018
2018
REPRODUCIBILITY OF HYPERPOLARIZED C-13 METABOLIC IMAGING IN PATIENTS WITH GLIOMA: NIMG-08.
A Autry, J Gordon, M Lafontaine, J Villanueva-Meyer, D Vigneron, ...
Neuro-oncology 20, 2018
2018
ATIM-22. PROGNOSTIC VALUE OF PTEN LOSS IN NEWLY DIAGNOSED GBM PATIENTS TREATED WITH AUTOLOGOUS HEAT SHOCK PROTEIN VACCINE
PA Leon, T Luks, M Lafontaine, J Clarke, S Chang, S Nelson, O Bloch, ...
Neuro-oncology 20 (Suppl 6), vi5, 2018
2018
NIMG-66. COMPARISON OF STEADY STATE AND DYNAMIC BRAIN METABOLISM BY USING 1H MRSI AND HYPERPOLARIZED [1-13C] PYRUVATE IMAGING IN PATIENTS WITH GLIOMA
Y Li, A Autry, J Gordon, J Crane, B Olson, M Lafontaine, I Park, ...
Neuro-Oncology 20 (Suppl 6), vi190, 2018
2018
NIMG-08. REPRODUCIBILITY OF HYPERPOLARIZED C-13 METABOLIC IMAGING IN PATIENTS WITH GLIOMA
A Autry, J Gordon, M Lafontaine, J Villanueva-Meyer, D Vigneron, ...
Neuro-Oncology 20 (Suppl 6), vi177, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20